Charles Zhou's Stock Ratings

UBS Analyst

Charles Zhou is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-11.2%

Smart Score

34.8%

Overall Average Return Percentile

20th

Number of Ratings

14
Buy NowGet Alert
03/17/2025FUTUBuy Now
Futu Hldgs
$114.4518.83%
Charles Zhou34%
$130 → $136MaintainsBuyGet Alert
01/05/2024FUTUBuy Now
Futu Hldgs
$114.45-41.46%
Charles Zhou34%
→ $67UpgradeNeutral → BuyGet Alert
03/08/2023ZYMEBuy Now
Zymeworks
$12.3429.66%
Charles Zhou34%
→ $16Reiterates → BuyGet Alert
12/16/2022FUTUBuy Now
Futu Holdings
$114.45-44.08%
Charles Zhou34%
$61 → $64DowngradeOutperform → NeutralGet Alert
06/28/2022COGTBuy Now
Cogent Biosciences
$7.25106.9%
Charles Zhou34%
→ $15Initiates → BuyGet Alert
05/05/2022MGNXBuy Now
Macrogenics
$2.21
Charles Zhou34%
DowngradeBuy → NeutralGet Alert
08/02/2021PMVPBuy Now
PMV Pharma
$1.274309.45%
Charles Zhou34%
→ $56Initiates → BuyGet Alert
06/28/2021RPTXBuy Now
Repare Therapeutics
$1.143935.09%
Charles Zhou34%
→ $46Initiates → BuyGet Alert
01/22/2020QDBuy Now
Qudian
$2.74
Charles Zhou34%
DowngradeOutperform → NeutralGet Alert
11/13/2017QDBuy Now
Qudian
$2.741104.38%
Charles Zhou34%
→ $33Initiates → OutperformGet Alert
08/25/2017LFCBuy Now
China Life Insurance Co
Charles Zhou34%
UpgradeUnderperform → NeutralGet Alert
03/01/2016LFCBuy Now
China Life Insurance Co
Charles Zhou34%
DowngradeOutperform → NeutralGet Alert
08/26/2015LFCBuy Now
China Life Insurance Co
Charles Zhou34%
UpgradeNeutral → OutperformGet Alert
01/17/2013LFCBuy Now
China Life Insurance Co
Charles Zhou34%
DowngradeNeutral → UnderperformGet Alert